In an article titled “Add-on liraglutide effective in obese diabetes patients” (published August 18, 2015) the 1.8-mg dosage of liraglutide was incorrectly identified. The trade name is Saxenda.
In an article titled “Add-on liraglutide effective in obese diabetes patients” (published August 18, 2015) the 1.8-mg dosage of liraglutide was incorrectly identified. The trade name is Saxenda.
EXPERT ANALYSIS FROM PMO LIVE SEATTLE (FRONTLINE MEDICAL NEWS) – Many advanced non–small cell ...
FROM JAMA INTERNAL MEDICINE Cognitive behavioral therapy significantly improved major depression but did not ...
FROM THE PROCEEDINGS OF THE NATIONAL ACADEMIES OF SCIENCE Adults with self-reported lactose intolerance ...
